ResMed ramps up ventilator production to tackle Covid-19

ResMed ramps up ventilator production to tackle Covid-19

Sleep apnoea treatment company ResMed (ASX: RMD) is one of Australia's great medical technology success stories, founded in Sydney by Dr. Peter Farrell in 1989 and now with offices all over the world.

Dual-listed on the New York Stock Exchange (NYSE), the company is headquartered in San Diego, California but has a state-of-the-art, 30-acre innovation and manufacturing center in the Greater Western Sydney suburb Bella Vista.

ResMed is a global leader in its field of expertise, but like Ford, GM and Tesla it is stepping up to the plate to help fill demand for other medical supplies, especially ventilators which are critical for treating severe cases of the virus.

"As a global leader in respiratory medicine, ResMed stands with the world in the face of the latest coronavirus disease COVID-19 and is ready to help mitigate its effects, helping people breathe while their immune system fights this virus," says ResMed CEO Mick Farrell, the founder's son.

"More than 7,500 ResMedians are working in over 140 countries for this purpose. We are working with governments, health authorities, hospitals, physicians, and patients worldwide to assess their needs, and to deliver the ventilation therapy that is essential to treat the respiratory complications of Covid-19.

"Our primary focus is to maximize the availability of ResMed ventilators and other respiratory support devices for the patients that need them most."

He says the company is taking "every measure possible" worldwide to maximise the production of ventilators, masks, and other respiratory devices.

"We are looking to double or triple the output of ventilators, and scale up ventilation mask production more than tenfold," says the executive.

"As global leaders in digital health, we're proud that many of our ventilators and bilevel respiratory devices are cloud-connected, enabling physicians and respiratory specialists to remotely monitor their patients.

"There could not be a clearer case for the use of digital health and remote monitoring of patients than this current crisis with a virus that is so contagious stemming from direct human contact."

Farrell expresses his gratitude to the global ResMed team for working through today's challenges to help treat an increasing number of Covid-19 patients.

"I'd like to call out first-responder ResMedians in China's Hubei province, the epicenter of the coronavirus outbreak, in particular one ResMed hero who, since early January, has donned a positive pressure hazmat suit, and helped set up thousands of people on ResMed ventilators and ResMed masks," he says.

"There are also 100-plus ResMedians from Malaysia who in mid-March volunteered to keep working in our Singapore manufacturing plant when Malaysia closed its borders, relocating to live near our plant in Singapore, spending weeks away from their families, so they can continue to produce as many lifesaving ventilators and ventilation masks as possible."

Updated at 6:53pm AEDT on 24 March 2020.

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

Deliver on sustainable business promises with Modern Group’s WincovER rating
Partner Content
As a business owner, you’ll know that sustainability is a core part of developing...
Modern Group
Advertisement

Related Stories

Balmain Leagues Club $500m redevelopment with Rozelle Village planned to start by mid-2023

Balmain Leagues Club $500m redevelopment with Rozelle Village planned to start by mid-2023

Chinese developer Heworth has rejigged its plans for the redevelopm...

Butter Insurance raises $1.3m to roll out insurance-at-checkout vision

Butter Insurance raises $1.3m to roll out insurance-at-checkout vision

Sydney-based insurtech Butter Insurance is gearing up for its natio...

TMG Developments looks to sell Sydney's iconic Manly Wharf

TMG Developments looks to sell Sydney's iconic Manly Wharf

The family-owned company that redeveloped the Manly Wharf as a food...

Ellume plucked out of administration by rapid test competitor for $57m

Ellume plucked out of administration by rapid test competitor for $57m

Brisbane-based rapid COVID-19 test maker Ellume has been plucked ou...